ISRCTN10836802Completed未知
ong-term follow-up of patients with positive tests for HPV in 1990-1992, comparing HPV status at baseline with the risk of cervical intraepithelial neoplasia grade 3 or higher (CIN3+) in the follow-up period of 30 years
niversity Hospital of North Norway0 sites642 target enrollmentStarted: December 23, 2020Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 642
Study Overview
Brief Summary
2021 results in https://pubmed.ncbi.nlm.nih.gov/34158090/ (added 24/06/2021)
Study Design
- Study Type
- Observational
Eligibility Criteria
- Sex
- Female
Inclusion Criteria
- •All women referred to the HPV outpatient clinic at the University Hospital of Northern Norway (UNN) in 1990-1992, with an HPV test at baseline
Exclusion Criteria
- •History of medical or surgical treatment for cervical cancer.
Investigators
Similar Trials
Completed
Not Applicable
ong-term follow up of patients in European Vasculitis Study Group clinical trialsAnti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV), granulomatosis with polyangiitis (GPA, Wegener’s granulomatosis (WG)) or microscopic polyangiitis (MPA)Circulatory SystemOther necrotizing vasculopathiesISRCTN52952998Skane University Hospital Malmö-Lund, Sweden875
Recruiting
Not Applicable
ong term follow up of the clinical and immunological responses following HPV 16 E6/E7 synthetic long peptides vaccination in women with HPV 16 positive vulvar intraepithelial neoplasia grade 3VINvulvair intraepithelial neoplasia10038594NL-OMON36101eids Universitair Medisch Centrum19
Completed
Not Applicable
Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) PatientsPatients Transplanted With NiCord/CordIn (Omidubicel)NCT02039557Gamida Cell ltd33
Active, not recruiting
Phase 1
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19Advanced lymphoid malignanciesMedDRA version: 20.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 100000004864EUCTR2016-000297-38-BEInstitut de Recherches Internationales Servier (I.R.I.S)200
Active, not recruiting
Phase 1
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19Advanced lymphoid malignanciesMedDRA version: 20.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 100000004864EUCTR2016-000297-38-FRInstitut de Recherches Internationales Servier (I.R.I.S)200